Search results
As Chief Business Officer, Michael Pine draws on his more than 20 years of industry experience in business development & licensing, commercial, and financial functions to generate growth and drive strategy at Eyepoint Pharmaceuticals.
View the profiles of people named Michael Pine. Join Facebook to connect with Michael Pine and others you may know. Facebook gives people the power to...
Dec 7, 2023 · Michael Pine, the Chief Corporate Development and Strategy Officer of EyePoint Pharmaceuticals, sold 45,000 shares of the company's stock on December 4, 2023.
Mr. Pine has developed a diverse set of skills and extensive deal sheets over his 20+ years of strategic and corporate development experience working at both large and small public pharmaceutical companies.
View Michael Pine’s profile on LinkedIn, a professional community of 1 billion members. Over 20 years of relevant experience in small, medium and large pharmaceutical companies…
Sep 25, 2020 · MONTREAL, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF), today announced the appointment of Michael Pine as Senior Vice President of Business Development and Strategy, effective September 21, 2020. Mr.
Sep 25, 2020 · MONTREAL, Sept. 25, 2020 -- Medexus Pharmaceuticals Inc. , today announced the appointment of Michael Pine as Senior Vice President of Business Development and Strategy, effective September 21,...
